HeartBeam, Inc. (BEAT) Fair Value 2026

BEAT · Health Information Services ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

4.7 /10

32 fundamental signals · 0 models active

Value Trap Risk

LOW (34/100)

Quick Summary — As of 2026-08-28, HeartBeam, Inc. (BEAT) trades at $0.47. QOC: 4.7/10. Value Trap Risk: 34/100 (LOW). 0/13 models active.

Key Facts

Ticker
BEAT
Price
$0.47
Quality Score
4.7/10
Value Trap Risk
34/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Below-average Quality Score of 4.7/10 signals weak fundamentals

What Fair Value Does Each Model Give BEAT?

0 Intrinsic Value Models vs. Current Price ($0.47)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is HeartBeam, Inc. (BEAT) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, HeartBeam, Inc. currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About BEAT?

0 of 13 models are currently active for BEAT. See which stocks rank higher →

How Does BEAT Rank in Health Information Services?

Among 55 Health Information Services stocks, BEAT ranks #47 by Quality of Company score. CirclFi's QOC score of 4.7/10 evaluates 32 fundamental signals. A score of 4.7 reflects mixed fundamentals.

See all Most Undervalued Health Information Services Stocks →

HeartBeam, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is BEAT a Value Trap?

CirclFi's Value Trap algorithm assigns BEAT a score of 34/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for HeartBeam, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, HeartBeam, Inc. scores 4.7 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every BEAT valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy HeartBeam, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Health Information Services Stocks Should You Also Analyze?

11 related Health Information Services stocks with 13-model coverage

ONMDOneMedNet CorporationQOC 4.8MSPRMSP Recovery, Inc.QOC 4.7VSEEVSee Health, Inc.QOC 4.8RVRCRevium Rx.QOC 4.5WORXSCWorx CorpQOC 4.8VYNDVynleads, Inc.QOC 4.1SPOKSpok Holdings, Inc.QOC 8.6BTSGBrightSpring Health Services, Inc.QOC 7.2DRIODarioHealth Corp.QOC 6.0DOCSDoximity, Inc.QOC 9.6HQYHealthEquity, Inc.QOC 9.5

Read investment analysis: ONMD · MSPR · VSEE · RVRC · WORX · VYND · SPOK · BTSG · DRIO · DOCS · HQY

Which Other Stocks Have a Similar Quality Score to BEAT?

7 companies across all industries closest to BEAT’s Quality of Company score of 4.7/10.

IPSTIP Strategy Holdings, Inc.QOC 4.7OBAIOur Bond, Inc.QOC 4.7LANVLanvin Group Holdings LimitedQOC 4.7CMMBChemomab Therapeutics Ltd.QOC 4.7MNYMoneyHero LimitedQOC 4.7RYESRise Gold Corp.QOC 4.7NVDANVIDIA CorporationQOC 10.0

Read investment analysis: IPST · OBAI · LANV · CMMB · MNY · RYES · NVDA

Where Does BEAT Sit in CirclFi's Health Information Services Rankings?

BEAT is ranked against every other Health Information Services stock CirclFi covers in each of these screens.

See all Health Information Services stocks ranked →

What Else Do Investors Ask About HeartBeam, Inc.’s Valuation?

What is HeartBeam, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for HeartBeam, Inc. (BEAT). The Quality of Company score is 4.7/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is BEAT overvalued or undervalued right now?

At $0.47, 0 of 0 active models suggest BEAT may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits HeartBeam, Inc.'s business model in Health Information Services.

What does a Quality of Company score of 4.7 mean for BEAT?

HeartBeam, Inc.'s QOC of 4.7/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on BEAT?

CirclFi analyzes BEAT with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is BEAT a value trap in 2026?

HeartBeam, Inc.'s Value Trap score is 34/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns HeartBeam, Inc. (BEAT) a Quality of Company score of 4.7/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/BEAT/ · Methodology
Primary sources for this BEAT valuation
  • Financial statements: HeartBeam, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001779372) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for BEAT as of ; valuations recomputed .